| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.23 | 4e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.16 | 0.004 |